| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.938 | 0.001 | 0.938 | Cystathionine beta-synthase inhibitor | 0.933 0.001 CID_154699706 | ||
| 0.908 | 0.003 | 0.915 | Caspase 9 stimulant | 0.915 0.003 CID_154699706 | CID_154699706 | |
| 0.873 | 0.004 | 0.873 | 12-Lipoxygenase inhibitor | 0.18 0.174 CID_154699706 | ||
| 0.872 | 0.003 | 0.883 | Free radical scavenger | 0.883 0.003 CID_154699706 | CID_154699706 | |
| 0.867 | 0.004 | 0.911 | Antioxidant | 0.911 0.003 CID_154699706 | CID_154699706 | |
| 0.865 | 0.004 | 0.865 | 15-Lipoxygenase inhibitor | |||
| 0.85 | 0.004 | 0.85 | Aryl hydrocarbon receptor agonist | 0.327 0.054 CID_154699706 | ||
| 0.851 | 0.011 | 0.851 | Apoptosis agonist | 0.838 0.012 CID_154699706 | ||
| 0.813 | 0.004 | 0.813 | Aldehyde oxidase inhibitor | 0.237 0.087 CID_154699706 | ||
| 0.803 | 0.002 | 0.803 | Peroxidase inhibitor | 0.352 0.028 CID_154699706 | ||
| 0.81 | 0.017 | 0.965 | Alpha-glucosidase inhibitor | 0.965 0.004 CID_154699706 | CID_154699706 | |
| 0.78 | 0.004 | 0.78 | Lipoxygenase inhibitor | 0.214 0.127 CID_154699706 | ||
| 0.745 | 0.005 | 0.745 | Amyloid beta aggregation inhibitor | 0.603 0.008 CID_154699706 | ||
| 0.731 | 0.005 | 0.731 | Caspase 3 stimulant | 0.639 0.008 CID_154699706 | ||
| 0.711 | 0.003 | 0.72 | NADPH oxidase inhibitor | 0.72 0.002 CID_154699706 | CID_154699706 | |
| 0.706 | 0.003 | 0.908 | Xanthine oxidase inhibitor | 0.908 0.002 CID_154699706 | CID_154699706 | |
| 0.707 | 0.004 | 0.707 | Superoxide dismutase inhibitor | 0.207 0.11 CID_154699706 | ||
| 0.703 | 0.004 | 0.703 | MAO A inhibitor | 0.084 0.077 CID_154699706 | ||
| 0.703 | 0.004 | 0.962 | Monophenol monooxygenase inhibitor | 0.962 0.002 CID_154699706 | CID_154699706 | |
| 0.698 | 0.003 | 0.845 | Amylase inhibitor | 0.845 0.001 CID_154699706 | CID_154699706 | |
| 0.696 | 0.005 | 0.851 | Histamine release inhibitor | 0.851 0.003 CID_154699706 | CID_154699706 | |
| 0.69 | 0.004 | 0.69 | MAO inhibitor | |||
| 0.705 | 0.02 | 0.899 | Transcription factor NF kappa B inhibitor | 0.899 0.006 CID_154699706 | CID_154699706 | |
| 0.679 | 0.005 | 0.715 | Hypoxia-inducible factor 1 alpha inhibitor | 0.715 0.004 CID_154699706 | CID_154699706 | |
| 0.677 | 0.004 | 0.677 | Breast cancer-resistant protein inhibitor | 0.162 0.02 CID_154699706 | ||
| 0.676 | 0.003 | 0.676 | Interleukin 4 antagonist | 0.399 0.005 CID_154699706 | ||
| 0.679 | 0.035 | 0.84 | Antiinflammatory | 0.84 0.01 CID_154699706 | CID_154699706 | |
| 0.646 | 0.002 | 0.646 | Carbonic anhydrase III inhibitor | 0.42 0.004 CID_154699706 | ||
| 0.646 | 0.004 | 0.646 | GABA C receptor rho-3 antagonist | |||
| 0.641 | 0.001 | 0.641 | Creatine kinase inhibitor | 0.236 0.006 CID_154699706 | ||
| 0.623 | 0.003 | 0.796 | Carbonic anhydrase XIII inhibitor | 0.796 0.002 CID_154699706 | CID_154699706 | |
| 0.623 | 0.004 | 0.647 | NOS3 expression enhancer | 0.647 0.004 CID_154699706 | CID_154699706 | |
| 0.606 | 0.005 | 0.606 | P-glycoprotein inhibitor | 0.409 0.015 CID_154699706 | ||
| 0.589 | 0.005 | 0.589 | Pyruvate kinase inhibitor | 0.355 0.032 CID_154699706 | ||
| 0.592 | 0.01 | 0.651 | Apoptosis antagonist | 0.651 0.005 CID_154699706 | CID_154699706 | |
| 0.588 | 0.011 | 0.588 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.575 | 0.003 | 0.575 | Carbonic anhydrase VI inhibitor | 0.33 0.005 CID_154699706 | ||
| 0.559 | 0.005 | 0.795 | Melanin inhibitor | 0.795 0.002 CID_154699706 | CID_154699706 | |
| 0.556 | 0.003 | 0.556 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.424 0.006 CID_154699706 | ||
| 0.577 | 0.028 | 0.577 | Prostaglandin dehydrogenase inhibitor | |||
| 0.551 | 0.002 | 0.551 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.162 0.016 CID_154699706 | ||
| 0.558 | 0.011 | 0.74 | Antiamyloidogenic | 0.74 0.004 CID_154699706 | CID_154699706 | |
| 0.551 | 0.012 | 0.684 | Nitric oxide antagonist | 0.684 0.006 CID_154699706 | CID_154699706 | |
| 0.537 | 0.012 | 0.756 | Hypoglycemic | 0.756 0.004 CID_154699706 | CID_154699706 | |
| 0.534 | 0.011 | 0.657 | Tumour necrosis factor alpha release inhibitor | 0.657 0.005 CID_154699706 | CID_154699706 | |
| 0.531 | 0.009 | 0.531 | RNA-directed DNA polymerase inhibitor | 0.468 0.013 CID_154699706 | ||
| 0.526 | 0.005 | 0.548 | Lipid peroxidase inhibitor | 0.548 0.004 CID_154699706 | CID_154699706 | |
| 0.54 | 0.022 | 0.64 | 5 Hydroxytryptamine release inhibitor | 0.64 0.007 CID_154699706 | CID_154699706 | |
| 0.519 | 0.007 | 0.519 | Tubulin antagonist | 0.178 0.045 CID_154699706 | ||
| 0.514 | 0.006 | 0.516 | Topoisomerase II inhibitor | 0.516 0.006 CID_154699706 | CID_154699706 | |
| 0.502 | 0.012 | 0.542 | Vasodilator | 0.542 0.009 CID_154699706 | CID_154699706 | |
| 0.491 | 0.005 | 0.592 | DNA methyltransferase I inhibitor | 0.592 0.004 CID_154699706 | CID_154699706 | |
| 0.497 | 0.016 | 0.862 | Vasodilator, coronary | 0.862 0.003 CID_154699706 | CID_154699706 | |
| 0.487 | 0.008 | 0.487 | Dual specificity phosphatase 3 inhibitor | 0.149 0.097 CID_154699706 | ||
| 0.486 | 0.007 | 0.486 | Dual specificity phosphatase inhibitor | 0.153 0.09 CID_154699706 | ||
| 0.476 | 0.002 | 0.572 | Nitric-oxide synthase stimulant | 0.572 0.002 CID_154699706 | CID_154699706 | |
| 0.477 | 0.005 | 0.477 | MAO B inhibitor | |||
| 0.486 | 0.015 | 0.656 | DNA damaging | 0.656 0.006 CID_154699706 | CID_154699706 | |
| 0.489 | 0.025 | 0.714 | Spasmolytic | 0.714 0.005 CID_154699706 | CID_154699706 | |
| 0.452 | 0.004 | 0.452 | Topoisomerase II alpha inhibitor | 0.42 0.004 CID_154699706 | ||
| 0.453 | 0.009 | 0.655 | Hepatoprotectant | 0.655 0.004 CID_154699706 | CID_154699706 | |
| 0.451 | 0.008 | 0.57 | DNA methylase inhibitor | 0.57 0.004 CID_154699706 | CID_154699706 | |
| 0.448 | 0.005 | 0.448 | Acetylcholinesterase inhibitor | 0.226 0.026 CID_154699706 | ||
| 0.445 | 0.008 | 0.445 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.442 | 0.006 | 0.535 | Protein kinase stimulant | 0.535 0.004 CID_154699706 | CID_154699706 | |
| 0.517 | 0.082 | 0.517 | DNA polymerase beta inhibitor | |||
| 0.44 | 0.005 | 0.44 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.435 | 0.005 | 0.634 | Alkaline phosphatase inhibitor | 0.634 0.003 CID_154699706 | CID_154699706 | |
| 0.475 | 0.048 | 0.734 | Antibacterial | 0.734 0.006 CID_154699706 | CID_154699706 | |
| 0.428 | 0.004 | 0.428 | M18 aspartyl aminopeptidase inhibitor | 0.149 0.053 CID_154699706 | ||
| 0.423 | 0.002 | 0.423 | Xanthine dehydrogenase inhibitor | 0.206 0.004 CID_154699706 | ||
| 0.429 | 0.01 | 0.669 | Non-steroidal antiinflammatory agent | 0.669 0.004 CID_154699706 | CID_154699706 | |
| 0.421 | 0.005 | 0.421 | Chelator | 0.222 0.021 CID_154699706 | ||
| 0.498 | 0.083 | 0.498 | DNA directed DNA polymerase inhibitor | 0.26 0.186 CID_154699706 | ||
| 0.416 | 0.005 | 0.416 | Tumour necrosis factor antagonist | 0.137 0.117 CID_154699706 | ||
| 0.414 | 0.008 | 0.414 | Protein-tyrosine phosphatase inhibitor | 0.305 0.018 CID_154699706 | ||
| 0.407 | 0.002 | 0.407 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.267 0.003 CID_154699706 | ||
| 0.416 | 0.016 | 0.416 | Transcription factor STAT inhibitor | |||
| 0.402 | 0.005 | 0.402 | 5-Lipoxygenase inhibitor | |||
| 0.383 | 0.004 | 0.383 | Carbonic anhydrase XV inhibitor | 0.108 0.057 CID_154699706 | ||
| 0.375 | 0.004 | 0.375 | GABA C receptor rho-2 antagonist | 0.124 0.118 CID_154699706 | ||
| 0.368 | 0.004 | 0.368 | Macrophage migration inhibitory factor inhibitor | |||
| 0.356 | 0.002 | 0.356 | D-Ala-D-Ala ligase inhibitor | 0.1 0.029 CID_154699706 | ||
| 0.38 | 0.026 | 0.38 | Antimitotic | 0.178 0.098 CID_154699706 | ||
| 0.355 | 0.005 | 0.355 | Telomerase inhibitor | 0.081 0.044 CID_154699706 | ||
| 0.355 | 0.004 | 0.355 | HIV-1 integrase (3'-Processing) inhibitor | 0.17 0.012 CID_154699706 | ||
| 0.348 | 0.003 | 0.348 | Multidrug resistance-associated protein 1 inhibitor | 0.271 0.004 CID_154699706 | ||
| 0.371 | 0.031 | 0.371 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.141 0.138 CID_154699706 | ||
| 0.343 | 0.004 | 0.343 | Aldose reductase inhibitor | 0.317 0.004 CID_154699706 | ||
| 0.352 | 0.013 | 0.352 | Cholinergic | 0.15 0.077 CID_154699706 | ||
| 0.365 | 0.029 | 0.764 | Angiogenesis stimulant | 0.764 0.004 CID_154699706 | CID_154699706 | |
| 0.339 | 0.004 | 0.339 | HIV-1 integrase (Strand Transfer) inhibitor | 0.162 0.012 CID_154699706 | ||
| 0.378 | 0.053 | 0.378 | Streptokinase A inhibitor | |||
| 0.328 | 0.012 | 0.328 | Amyloid beta precursor protein antagonist | |||
| 0.325 | 0.009 | 0.325 | Protein kinase (CK2) alpha inhibitor | |||
| 0.32 | 0.005 | 0.32 | Estrogen receptor beta antagonist | 0.108 0.05 CID_154699706 | ||
| 0.316 | 0.005 | 0.764 | Beta glucuronidase inhibitor | 0.764 0.002 CID_154699706 | CID_154699706 | |
| 0.31 | 0.01 | 0.31 | Protein-tyrosine phosphatase 1B inhibitor | 0.254 0.016 CID_154699706 | ||
| 0.303 | 0.003 | 0.303 | Carbonic anhydrase VII inhibitor | 0.248 0.004 CID_154699706 | ||
| 0.302 | 0.004 | 0.302 | Histone deacetylase SIRT1 stimulant | 0.215 0.005 CID_154699706 | ||
| 0.302 | 0.004 | 0.302 | Histone deacetylase stimulant | 0.215 0.005 CID_154699706 | ||
| 0.316 | 0.02 | 0.316 | Mcl-1 antagonist | |||
| 0.391 | 0.096 | 0.795 | Cyclophilin D inhibitor | 0.795 0.007 CID_154699706 | CID_154699706 | |
| 0.304 | 0.01 | 0.304 | Heat shock protein 90 antagonist | |||
| 0.32 | 0.028 | 0.458 | Platelet adhesion inhibitor | 0.458 0.007 CID_154699706 | CID_154699706 | |
| 0.334 | 0.041 | 0.334 | Dyrk kinase inhibitor | |||
| 0.302 | 0.014 | 0.302 | Heat shock protein 90 alpha antagonist | |||
| 0.294 | 0.007 | 0.294 | Histidine decarboxylase inhibitor | |||
| 0.29 | 0.004 | 0.29 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.29 | 0.006 | 0.29 | Estrogen antagonist | 0.136 0.031 CID_154699706 | ||
| 0.278 | 0.006 | 0.309 | Alcohol dehydrogenase inhibitor | 0.309 0.005 CID_154699706 | CID_154699706 | |
| 0.275 | 0.005 | 0.275 | Uric acid excretion stimulant | 0.249 0.007 CID_154699706 | ||
| 0.277 | 0.012 | 0.277 | Butyrylcholinesterase inhibitor | |||
| 0.281 | 0.018 | 0.281 | Cytokine production inhibitor | |||
| 0.265 | 0.004 | 0.265 | Heat shock protein 70 antagonist | 0.256 0.004 CID_154699706 | ||
| 0.264 | 0.005 | 0.264 | Alpha tubulin antagonist | 0.061 0.029 CID_154699706 | ||
| 0.265 | 0.006 | 0.543 | AMP-activated protein kinase stimulant | 0.543 0.003 CID_154699706 | CID_154699706 | |
| 0.262 | 0.004 | 0.262 | Myeloperoxidase inhibitor | |||
| 0.263 | 0.006 | 0.263 | Aromatase inhibitor | |||
| 0.272 | 0.016 | 0.272 | Succinate dehydrogenase inhibitor | |||
| 0.344 | 0.09 | 0.519 | Immunosuppressant | 0.519 0.028 CID_154699706 | CID_154699706 | |
| 0.257 | 0.006 | 0.257 | Estrogen receptor alpha antagonist | |||
| 0.266 | 0.02 | 0.604 | Hemostatic | 0.604 0.003 CID_154699706 | CID_154699706 | |
| 0.251 | 0.005 | 0.251 | Beta tubulin antagonist | 0.049 0.048 CID_154699706 | ||
| 0.26 | 0.015 | 0.35 | Topoisomerase I inhibitor | 0.35 0.008 CID_154699706 | CID_154699706 | |
| 0.272 | 0.027 | 0.297 | Neurotrophic factor enhancer | 0.297 0.019 CID_154699706 | CID_154699706 | |
| 0.253 | 0.009 | 0.638 | Cyclooxygenase 3 inhibitor | 0.638 0.002 CID_154699706 | CID_154699706 | |
| 0.248 | 0.005 | 0.248 | Electron transport complex I inhibitor | 0.114 0.056 CID_154699706 | ||
| 0.319 | 0.077 | 0.749 | Antithrombotic | 0.749 0.006 CID_154699706 | CID_154699706 | |
| 0.254 | 0.02 | 0.254 | Cyclooxygenase 1 inhibitor | 0.191 0.038 CID_154699706 | ||
| 0.238 | 0.004 | 0.238 | DOPA decarboxylase inhibitor | 0.1 0.076 CID_154699706 | ||
| 0.236 | 0.003 | 0.236 | Fatty acid synthase inhibitor | 0.139 0.005 CID_154699706 | ||
| 0.235 | 0.005 | 0.235 | CDC25A inhibitor | 0.111 0.023 CID_154699706 | ||
| 0.259 | 0.03 | 0.259 | Insulin sensitizer | 0.246 0.037 CID_154699706 | ||
| 0.23 | 0.005 | 0.23 | Cyclin B3 inhibitor | |||
| 0.234 | 0.008 | 0.234 | Protein kinase C zeta inhibitor | |||
| 0.275 | 0.052 | 0.467 | Cyclic AMP phosphodiesterase inhibitor | 0.467 0.009 CID_154699706 | CID_154699706 | |
| 0.248 | 0.027 | 0.248 | Cyclooxygenase inhibitor | 0.237 0.029 CID_154699706 | ||
| 0.269 | 0.048 | 0.269 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.272 | 0.054 | 0.272 | Interleukin antagonist | 0.199 0.085 CID_154699706 | ||
| 0.218 | 0.005 | 0.218 | Carbonic anhydrase V inhibitor | |||
| 0.234 | 0.023 | 0.309 | Insulin secretagoues | 0.309 0.011 CID_154699706 | CID_154699706 | |
| 0.215 | 0.005 | 0.215 | Transcription factor STAT6 inhibitor | |||
| 0.224 | 0.015 | 0.224 | Protein kinase (CK2) inhibitor | |||
| 0.217 | 0.01 | 0.325 | Photosensitizer | 0.325 0.004 CID_154699706 | CID_154699706 | |
| 0.3 | 0.093 | 0.3 | Thyroid hormone antagonist | |||
| 0.299 | 0.098 | 0.299 | Vasodilator, peripheral | 0.223 0.151 CID_154699706 | ||
| 0.204 | 0.007 | 0.204 | GABA C receptor rho-1 antagonist | |||
| 0.257 | 0.062 | 0.257 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.204 | 0.01 | 0.204 | Urease inhibitor | |||
| 0.217 | 0.024 | 0.241 | Aldehyde dehydrogenase inhibitor | 0.241 0.019 CID_154699706 | CID_154699706 | |
| 0.211 | 0.019 | 0.211 | Toll-Like receptor 2 antagonist | 0.109 0.09 CID_154699706 | ||
| 0.287 | 0.095 | 0.287 | Thyroid hormone beta antagonist | |||
| 0.209 | 0.017 | 0.209 | CF transmembrane conductance regulator agonist | 0.161 0.059 CID_154699706 | ||
| 0.199 | 0.008 | 0.199 | Estrogen agonist | 0.157 0.011 CID_154699706 | ||
| 0.214 | 0.023 | 0.231 | Mannose-6-phosphate isomerase inhibitor | 0.231 0.017 CID_154699706 | CID_154699706 | |
| 0.193 | 0.005 | 0.193 | Carbonic anhydrase VA inhibitor | |||
| 0.209 | 0.028 | 0.209 | Cyclooxygenase 2 inhibitor | 0.206 0.029 CID_154699706 | ||
| 0.263 | 0.083 | 0.263 | 5 Hydroxytryptamine release stimulant | 0.205 0.117 CID_154699706 | ||
| 0.257 | 0.078 | 0.257 | Transcription factor STAT3 inhibitor | |||
| 0.2 | 0.026 | 0.408 | Alkylator | 0.408 0.007 CID_154699706 | CID_154699706 | |
| 0.179 | 0.016 | 0.179 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.197 | 0.036 | 0.197 | Bone formation stimulant | 0.15 0.059 CID_154699706 | ||
| 0.164 | 0.005 | 0.295 | Carbonic anhydrase XIV inhibitor | 0.295 0.004 CID_154699706 | CID_154699706 | |
| 0.268 | 0.11 | 0.278 | Angiogenesis inhibitor | 0.278 0.104 CID_154699706 | CID_154699706 | |
| 0.164 | 0.007 | 0.164 | HIV-1 integrase inhibitor | 0.099 0.025 CID_154699706 | ||
| 0.162 | 0.005 | 0.162 | CDC25B inhibitor | 0.068 0.04 CID_154699706 | ||
| 0.175 | 0.018 | 0.175 | Papain-like protease (SARS coronavirus) inhibitor | 0.113 0.101 CID_154699706 | ||
| 0.154 | 0.005 | 0.154 | Aryl hydrocarbon receptor antagonist | |||
| 0.167 | 0.019 | 0.354 | DNA repair enzyme inhibitor | 0.354 0.004 CID_154699706 | CID_154699706 | |
| 0.169 | 0.021 | 0.169 | GABA C receptor antagonist | |||
| 0.173 | 0.026 | 0.298 | Antineoplastic antibiotic | 0.298 0.01 CID_154699706 | CID_154699706 | |
| 0.161 | 0.017 | 0.161 | Phosphodiesterase 4D inhibitor | |||
| 0.152 | 0.009 | 0.152 | Thioredoxin reductase inhibitor | 0.087 0.045 CID_154699706 | ||
| 0.152 | 0.01 | 0.158 | T cell inhibitor | 0.158 0.009 CID_154699706 | CID_154699706 | |
| 0.144 | 0.003 | 0.144 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.154 | 0.015 | 0.174 | Thioredoxin inhibitor | 0.174 0.011 CID_154699706 | CID_154699706 | |
| 0.151 | 0.014 | 0.151 | Keratolytic | |||
| 0.141 | 0.008 | 0.141 | Estrogen receptor beta agonist | 0.089 0.013 CID_154699706 | ||
| 0.182 | 0.051 | 0.182 | Arachidonic acid antagonist | |||
| 0.165 | 0.038 | 0.165 | Cholesterol synthesis inhibitor | 0.128 0.058 CID_154699706 | ||
| 0.148 | 0.023 | 0.148 | Androgen antagonist | |||
| 0.128 | 0.004 | 0.128 | Transcription factor RelA inhibitor | |||
| 0.136 | 0.013 | 0.136 | Lipase inhibitor | 0.093 0.031 CID_154699706 | ||
| 0.127 | 0.004 | 0.127 | Catechol O-methyltransferase inhibitor | |||
| 0.154 | 0.034 | 0.492 | Expectorant | 0.492 0.004 CID_154699706 | CID_154699706 | |
| 0.173 | 0.055 | 0.336 | Interferon gamma antagonist | 0.336 0.015 CID_154699706 | CID_154699706 | |
| 0.14 | 0.029 | 0.14 | Sphingomyelinase inhibitor | 0.108 0.052 CID_154699706 | ||
| 0.138 | 0.029 | 0.184 | Toll-Like receptor 4 antagonist | 0.184 0.009 CID_154699706 | CID_154699706 | |
| 0.13 | 0.021 | 0.227 | Interleukin 12 antagonist | 0.227 0.005 CID_154699706 | CID_154699706 | |
| 0.144 | 0.036 | 0.166 | Mucolytic | 0.166 0.024 CID_154699706 | CID_154699706 | |
| 0.126 | 0.02 | 0.126 | Interleukin 5 antagonist | 0.121 0.023 CID_154699706 | ||
| 0.114 | 0.008 | 0.114 | CD45 antagonist | |||
| 0.151 | 0.049 | 0.185 | DNA polymerase I inhibitor | 0.185 0.033 CID_154699706 | CID_154699706 | |
| 0.149 | 0.047 | 0.149 | Antibacterial (Helicobacter pylori) | |||
| 0.113 | 0.011 | 0.127 | Neuraminidase inhibitor | 0.127 0.009 CID_154699706 | CID_154699706 | |
| 0.126 | 0.026 | 0.126 | ABCA1 expression enhancer | |||
| 0.144 | 0.045 | 0.19 | DNA intercalator | 0.19 0.029 CID_154699706 | CID_154699706 | |
| 0.106 | 0.008 | 0.106 | Glutamate (mGluR7) antagonist | |||
| 0.111 | 0.014 | 0.144 | Neuraminidase (influenza) inhibitor | 0.144 0.008 CID_154699706 | CID_154699706 | |
| 0.133 | 0.037 | 0.397 | Mediator release inhibitor | 0.397 0.005 CID_154699706 | CID_154699706 | |
| 0.115 | 0.019 | 0.115 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.106 | 0.012 | 0.106 | Protease activated receptor antagonist | |||
| 0.147 | 0.055 | 0.147 | Farnesoid X receptor antagonist | |||
| 0.101 | 0.01 | 0.101 | Heat shock protein 90 beta antagonist | |||
| 0.099 | 0.009 | 0.099 | Estrogen receptor alpha agonist | |||
| 0.093 | 0.005 | 0.093 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.152 | 0.065 | 0.152 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.208 | 0.122 | 0.208 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.091 | 0.005 | 0.091 | Ryanodine receptor antagonist | |||
| 0.09 | 0.005 | 0.09 | Dopamine D5 agonist | |||
| 0.111 | 0.028 | 0.111 | Glutathione S-transferase inhibitor | |||
| 0.103 | 0.019 | 0.225 | Carbonic anhydrase XII inhibitor | 0.225 0.007 CID_154699706 | CID_154699706 | |
| 0.103 | 0.02 | 0.103 | Leukotriene antagonist | 0.083 0.03 CID_154699706 | ||
| 0.137 | 0.054 | 0.137 | Proteasome inhibitor | |||
| 0.099 | 0.017 | 0.106 | Maillard reaction inhibitor | 0.106 0.014 CID_154699706 | CID_154699706 | |
| 0.116 | 0.035 | 0.116 | Phosphodiesterase IV inhibitor | |||
| 0.16 | 0.08 | 0.16 | Neurotensin receptor agonist | |||
| 0.103 | 0.024 | 0.103 | Leukotriene synthesis inhibitor | |||
| 0.15 | 0.074 | 0.15 | Phospholipase A2 inhibitor | |||
| 0.146 | 0.07 | 0.146 | Adenylate cyclase stimulant | |||
| 0.151 | 0.077 | 0.287 | Hexokinase inhibitor | 0.287 0.012 CID_154699706 | CID_154699706 | |
| 0.088 | 0.016 | 0.088 | Cyclin B1 inhibitor | |||
| 0.084 | 0.013 | 0.084 | Cyclin B2 inhibitor | |||
| 0.081 | 0.011 | 0.122 | Glucose-6-phosphate translocase inhibitor | 0.122 0.004 CID_154699706 | CID_154699706 | |
| 0.254 | 0.184 | 0.254 | Transcription factor inhibitor | |||
| 0.158 | 0.09 | 0.158 | Phospholipase C inhibitor | 0.139 0.131 CID_154699706 | ||
| 0.174 | 0.108 | 0.174 | Histone acetyltransferase inhibitor | |||
| 0.104 | 0.04 | 0.104 | Ornithine decarboxylase inhibitor | 0.079 0.069 CID_154699706 | ||
| 0.071 | 0.007 | 0.134 | Arginase inhibitor | 0.134 0.003 CID_154699706 | CID_154699706 | |
| 0.083 | 0.021 | 0.083 | Carbonic anhydrase VB inhibitor | |||
| 0.108 | 0.047 | 0.108 | Prolactin inhibitor | |||
| 0.271 | 0.211 | 0.271 | MAP kinase 1 inhibitor | |||
| 0.207 | 0.147 | 0.207 | Insulysin inhibitor | |||
| 0.096 | 0.037 | 0.096 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.118 | 0.06 | 0.118 | TRPA1 agonist | |||
| 0.067 | 0.009 | 0.067 | GABA B receptor antagonist | |||
| 0.075 | 0.017 | 0.118 | Leukotriene B4 antagonist | 0.118 0.007 CID_154699706 | CID_154699706 | |
| 0.061 | 0.005 | 0.061 | Protein kinase (CK2) beta inhibitor | |||
| 0.115 | 0.061 | 0.115 | Nav1.5 sodium channel blocker | |||
| 0.073 | 0.019 | 0.073 | Cyclin B inhibitor | |||
| 0.068 | 0.015 | 0.068 | Squalene epoxidase inhibitor | |||
| 0.056 | 0.004 | 0.056 | Estrogen-related receptor beta antagonist | |||
| 0.091 | 0.04 | 0.127 | Na+ K+ transporting ATPase inhibitor | 0.127 0.013 CID_154699706 | CID_154699706 | |
| 0.076 | 0.027 | 0.076 | CDK4/cyclin D1 inhibitor | |||
| 0.159 | 0.11 | 0.159 | I kappa B kinase epsilon inhibitor | |||
| 0.084 | 0.035 | 0.084 | Dopamine agonist | |||
| 0.08 | 0.033 | 0.08 | Dopamine D1 antagonist | |||
| 0.104 | 0.057 | 0.104 | Anabolic | |||
| 0.066 | 0.019 | 0.066 | Topoisomerase II beta inhibitor | 0.062 0.021 CID_154699706 | ||
| 0.064 | 0.017 | 0.064 | CXC chemokine 1 receptor antagonist | |||
| 0.157 | 0.11 | 0.191 | Psychostimulant | 0.191 0.085 CID_154699706 | CID_154699706 | |
| 0.083 | 0.037 | 0.119 | Phosphodiesterase VI inhibitor | 0.119 0.012 CID_154699706 | CID_154699706 | |
| 0.064 | 0.018 | 0.064 | Potassium channel Kv1.3 blocker | |||
| 0.07 | 0.025 | 0.07 | Sphingosine kinase inhibitor | |||
| 0.142 | 0.101 | 0.215 | Interleukin 6 antagonist | 0.215 0.033 CID_154699706 | CID_154699706 | |
| 0.16 | 0.119 | 0.16 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.122 | 0.084 | 0.122 | Vanilloid 1 agonist | 0.119 0.089 CID_154699706 | ||
| 0.146 | 0.108 | 0.146 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.069 | 0.032 | 0.069 | Transcription factor AP-1 inhibitor | 0.067 0.034 CID_154699706 | ||
| 0.088 | 0.052 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.067 | 0.032 | 0.067 | Cyclin D1 inhibitor | |||
| 0.044 | 0.01 | 0.044 | ATP citrate lysase inhibitor | |||
| 0.065 | 0.031 | 0.065 | Protein kinase C eta inhibitor | |||
| 0.134 | 0.1 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.13 0.122 CID_154699706 | ||
| 0.094 | 0.061 | 0.094 | Potassium channel (Ca-activated) activator | |||
| 0.063 | 0.03 | 0.063 | Phosphatidylinositol 3-kinase gamma inhibitor | |||
| 0.17 | 0.139 | 0.539 | Immunostimulant | 0.539 0.024 CID_154699706 | CID_154699706 | |
| 0.097 | 0.067 | 0.097 | Bronchodilator | |||
| 0.076 | 0.049 | 0.076 | Adenosine A3 receptor antagonist | |||
| 0.034 | 0.007 | 0.034 | Dopamine D1 agonist | 0.029 0.01 CID_154699706 | ||
| 0.106 | 0.081 | 0.14 | Microtubule formation inhibitor | 0.14 0.043 CID_154699706 | CID_154699706 | |
| 0.052 | 0.028 | 0.052 | Adenosine deaminase inhibitor | |||
| 0.082 | 0.059 | 0.082 | Estrogen-related receptor beta agonist | |||
| 0.05 | 0.03 | 0.05 | Cholesterol esterase inhibitor | |||
| 0.148 | 0.13 | 0.148 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.084 | 0.067 | 0.145 | NADH dehydrogenase inhibitor | 0.145 0.019 CID_154699706 | CID_154699706 | |
| 0.09 | 0.073 | 0.09 | Bile acid receptor antagonist | |||
| 0.063 | 0.047 | 0.063 | Beta 3 adrenoreceptor antagonist | |||
| 0.043 | 0.028 | 0.043 | DNA gyrase subunit A inhibitor | |||
| 0.056 | 0.041 | 0.056 | Leukotriene C antagonist | |||
| 0.051 | 0.038 | 0.051 | Vanilloid 2 antagonist | |||
| 0.086 | 0.073 | 0.086 | Pim-1 kinase inhibitor | |||
| 0.042 | 0.031 | 0.042 | Carbonic anhydrase IV inhibitor | |||
| 0.024 | 0.013 | 0.024 | Estrone sulfatase inhibitor | |||
| 0.041 | 0.031 | 0.041 | Dopamine D5 antagonist | |||
| 0.063 | 0.054 | 0.063 | Potassium channel large-conductance Ca-activated activator | |||
| 0.031 | 0.024 | 0.031 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.076 | 0.07 | 0.076 | Caspase 7 inhibitor | |||
| 0.085 | 0.081 | 0.085 | Alpha 2c adrenoreceptor antagonist | |||
| 0.042 | 0.038 | 0.064 | Neuraminidase (Influenza A) inhibitor | 0.064 0.01 CID_154699706 | CID_154699706 | |
| 0.065 | 0.061 | 0.065 | Glutamate decarboxylase inhibitor | |||
| 0.073 | 0.07 | 0.073 | Calcium antagonist | |||
| 0.135 | 0.131 | 0.273 | ATPase inhibitor | 0.273 0.009 CID_154699706 | CID_154699706 | |
| 0.112 | 0.109 | 0.112 | Neurotrophic factor | |||
| 0.097 | 0.094 | 0.13 | Beta amyloid protein antagonist | 0.13 0.057 CID_154699706 | CID_154699706 | |
| 0.054 | 0.052 | 0.073 | Carbonic anhydrase inhibitor | 0.073 0.038 CID_154699706 | CID_154699706 | |
| 0.017 | 0.019 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.004 CID_154699706 | CID_154699706 | |
| 0.019 | 0.021 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.015 CID_154699706 | CID_154699706 | |
| 0.052 | 0.064 | 0.079 | Nitric oxide donor | 0.079 0.023 CID_154699706 | CID_154699706 | |
| 0.017 | 0.031 | 0.061 | Protein 30S ribosomal subunit inhibitor | 0.061 0.006 CID_154699706 | CID_154699706 | |
| 0.02 | 0.035 | 0.09 | Sodium/glucose cotransporter 2 inhibitor | 0.09 0.003 CID_154699706 | CID_154699706 | |
| 0.076 | 0.09 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 CID_154699706 | CID_154699706 | |
| 0.082 | 0.1 | 0.121 | Phosphodiesterase 6D inhibitor | 0.121 0.024 CID_154699706 | CID_154699706 | |
| 0.019 | 0.045 | 0.073 | Sodium/glucose cotransporter inhibitor | 0.073 0.004 CID_154699706 | CID_154699706 | |
| 0.168 | 0.198 | 0.375 | Cholesterol antagonist | 0.375 0.055 CID_154699706 | CID_154699706 | |
| 0.07 | 0.11 | 0.146 | UDP-glucose 4-epimerase inhibitor | 0.146 0.03 CID_154699706 | CID_154699706 | |
| 0.098 | 0.141 | 0.282 | Diuretic | 0.282 0.026 CID_154699706 | CID_154699706 | |
| 0.153 | 0.197 | 0.311 | DNA synthesis inhibitor | 0.311 0.04 CID_154699706 | CID_154699706 | |
| 0.046 | 0.098 | 0.065 | Lipocortins synthesis agonist | 0.065 0.028 CID_154699706 | CID_154699706 | |
| 0.032 | 0.087 | 0.043 | Glucose-6-phosphate isomerase inhibitor | 0.043 0.042 CID_154699706 | CID_154699706 | |
| 0.123 | 0.18 | 0.323 | Platelet antagonist | 0.323 0.045 CID_154699706 | CID_154699706 | |
| 0.08 | 0.138 | 0.131 | Alpha-N-acetylglucosaminidase inhibitor | 0.131 0.068 CID_154699706 | CID_154699706 | |
| 0.088 | 0.149 | 0.333 | Thrombolytic | 0.333 0.019 CID_154699706 | CID_154699706 | |
| 0.056 | 0.125 | 0.15 | Falcipain 2 inhibitor | 0.15 0.029 CID_154699706 | CID_154699706 | |
| 0.036 | 0.108 | 0.053 | Factor III inhibitor | 0.053 0.027 CID_154699706 | CID_154699706 | |
| 0.057 | 0.13 | 0.152 | Falcipain inhibitor | 0.152 0.03 CID_154699706 | CID_154699706 | |
| 0.034 | 0.107 | 0.099 | Heparanase inhibitor | 0.099 0.004 CID_154699706 | CID_154699706 | |
| 0.058 | 0.143 | 0.096 | Triose-phosphate isomerase inhibitor | 0.096 0.052 CID_154699706 | CID_154699706 | |
| 0.03 | 0.118 | 0.075 | Phosphofructokinase-1 inhibitor | 0.075 0.044 CID_154699706 | CID_154699706 | |
| 0.021 | 0.118 | 0.071 | Antibiotic Aminoglycoside-like | 0.071 0.006 CID_154699706 | CID_154699706 | |
| 0.084 | 0.181 | 0.248 | Cell wall synthesis inhibitor | 0.248 0.016 CID_154699706 | CID_154699706 | |
| 0.039 | 0.14 | 0.062 | Adenine nucleotide translocase inhibitor | 0.062 0.025 CID_154699706 | CID_154699706 | |
| 0.062 | 0.177 | 0.114 | Ribosomal protein S6 kinase inhibitor | 0.114 0.097 CID_154699706 | CID_154699706 | |
| 0.055 | 0.182 | 0.127 | Transcription factor NF kappa B stimulant | 0.127 0.022 CID_154699706 | CID_154699706 | |
| 0.02 | 0.161 | 0.096 | Protein 50S ribosomal subunit inhibitor | 0.096 0.014 CID_154699706 | CID_154699706 | |
| 0.021 | 0.176 | 0.33 | Selectin antagonist | 0.33 0.004 CID_154699706 | CID_154699706 | |
| 0.02 | 0.178 | 0.041 | Microtubule stabilization | 0.041 0.04 CID_154699706 | CID_154699706 | |
| 0.009 | 0.183 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.024 CID_154699706 | CID_154699706 | |
| 0.026 | 0.21 | 0.08 | DNA gyrase inhibitor | 0.08 0.027 CID_154699706 | CID_154699706 | |
| 0.018 | 0.215 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.046 CID_154699706 | CID_154699706 | |
| 0.069 | 0.286 | 0.267 | Hypolipemic | 0.267 0.06 CID_154699706 | CID_154699706 | |
| 0.066 | 0.288 | 0.214 | Interleukin agonist | 0.214 0.108 CID_154699706 | CID_154699706 | |
| 0.112 | 0.351 | 0.362 | Peptidyltransferase inhibitor | 0.362 0.01 CID_154699706 | CID_154699706 | |
| 0.014 | 0.27 | 0.03 | Toll-Like receptor 4 agonist | 0.03 0.012 CID_154699706 | CID_154699706 | |
| 0.089 | 0.413 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.049 CID_154699706 | CID_154699706 | |
| 0.025 | 0.531 | 0.206 | Cell adhesion inhibitor | 0.206 0.023 CID_154699706 | CID_154699706 | |
| 0.045 | 0.61 | 0.369 | Immunomodulator | 0.369 0.054 CID_154699706 | CID_154699706 | |
| 0.07 | 0.664 | 0.35 | Interleukin 2 agonist | 0.35 0.046 CID_154699706 | CID_154699706 | |
| 0.012 | 0.661 | 0.16 | Anticoagulant | 0.16 0.072 CID_154699706 | CID_154699706 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |